It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work — for…

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus…

With the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases. So it…

The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts have recognized that…

How difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find themselves envying…